Obesity drugs are evolving quickly, and what seemed revolutionary just a few years ago may soon become the starting point for an entirely new generation of treatments
Available at:
Going from $179 to $299 for semaglutide, or $279 to $399 for tirzepatide, is a significant monthly increase
However, they are still subject to state board of pharmacy oversight and must comply with USP compounding standards and Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, according to the Alliance for Pharmacy Compounding
In short, it creates weight loss via hormonal signaling, which reduces your appetite, helps you feel full longer, while also delaying gastric emptying and modulating satiety signals in your brain
One of the primary benefits is its ability to lower blood sugar levels